GENOMTEC S.A. ZY -10
Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company's flagship project is the Genomtec ID, a diagnostic platform that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analysi… Read more
GENOMTEC S.A. ZY -10 (4VI) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, GENOMTEC S.A. ZY -10 (4VI) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
GENOMTEC S.A. ZY -10 - Net Assets Trend (None–None)
This chart illustrates how GENOMTEC S.A. ZY -10's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for GENOMTEC S.A. ZY -10 (None–None)
The table below shows the annual net assets of GENOMTEC S.A. ZY -10 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to GENOMTEC S.A. ZY -10's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
GENOMTEC S.A. ZY -10 Competitors by Market Cap
The table below lists competitors of GENOMTEC S.A. ZY -10 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
4170
TWO:4170
|
$13.25 Million |
|
Associated Industries China Inc
TW:9912
|
$13.25 Million |
|
Dongil Metal Co. Ltd
KQ:109860
|
$13.26 Million |
|
BCM Resources Corporation
PINK:BCMRF
|
$13.26 Million |
|
Koil Energy Solutions Inc.
OTCQB:KLNG
|
$13.24 Million |
|
Netgem SA
PA:ALNTG
|
$13.24 Million |
|
SOSANDAR PLC LS -001
F:HXKB
|
$13.24 Million |
|
PXSTD
PINK:PXSTD
|
$13.24 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GENOMTEC S.A. ZY -10's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares GENOMTEC S.A. ZY -10's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently GENOMTEC S.A. ZY -10 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares GENOMTEC S.A. ZY -10's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GENOMTEC S.A. ZY -10 (4VI) | €- | N/A | N/A | $13.24 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |